Wearable Sensor Patents

Wearable sensor patents cover ECG single-lead cardiac monitoring innovations; PPG photoplethysmography heart rate and SpO2 innovations; continuous glucose monitoring CGM electrochemical sensor innovations; inertial measurement unit IMU and motion analysis innovations; and skin-based biomarker sensing innovations — with IP held by large consumer electronics companies, medical device companies, and digital health startups: MAJOR WEARABLE SENSOR PATENT HOLDERS: APPLE: 3,000+; specific Watch biosensors (specific specific Apple Watch Series 9 S9 chip: specific specific ECG electrocardiogram from specific specific lead-I from specific specific 5-electrode titanium band+crown from specific specific 256-500 Hz from specific specific 30-second recording from specific specific AF atrial fibrillation detection algorithm from specific specific PPV positive predictive value 98.5% FDA 510k from specific specific SpO2 oximetry from specific specific LED red 660 nm+green 525 nm+IR 940 nm from specific specific 3-LED photodiode array from specific specific ±2% accuracy 95-100% range from specific specific skin temperature sensor from specific specific thermistor 0.1°C resolution from specific specific background reading every 5s nightly from specific specific ovulation cycle tracking from specific specific crash detection from specific specific high-g accelerometer 256g peak from specific specific barometer from specific specific ML SUD sudden unexpected); DEXCOM: 1,000+; specific CGM (specific specific G7 CGM: specific specific electrochemical amperometric from specific specific glucose oxidase GOx enzyme from specific specific 10-day wear from specific specific MARD mean absolute relative difference 8.2% vs. specific specific YSI reference at specific specific 40-400 mg/dL from specific specific 5 min update interval from specific specific Bluetooth 5.0 transmission from specific specific 0.25× smaller than specific specific G6 from specific specific iCGM FDA Class II De Novo 2020 from specific specific low alarm 55 mg/dL at specific specific 5 min from specific specific direct-to-watch Apple/Android); ABBOTT DIABETES: 1,000+; specific Libre CGM (specific specific Libre 3 FSL3 Flash: specific specific 14-day wear from specific specific real-time 60s scan NFC 13.56 MHz from specific specific MARD 7.8% iCGM FDA 2022 Class II from specific specific 0-500 mg/dL range from specific specific factory-calibrated no fingerstick from specific specific 1-minute warm-up vs. specific specific 2-hour G7 from specific specific direct phone tap NFC+BLE 5.0 from specific specific Libre Sense lactate sweat future); GARMIN: 500+; WHOOP; WITHINGS; BIOBEAT; SAMSUNG; FITBIT/GOOGLE.

PPG optical heart rate and advanced waveform analysis innovations enabling new vital sign measurements from the wrist; single-lead ECG and AI-driven cardiac event detection innovations; and SpO2 pulse oximetry and multi-wavelength optical sensing innovations represent three core wearable biosensor patent domains: PPG OPTICAL SENSOR PATENTS: APPLE; GARMIN; SAMSUNG; VALENCELL; POLAR ELECTRO; MASIMO: specific PPG innovations (specific specific multi-wavelength PPG: specific specific LED array red 660 nm+green 520 nm+IR 940 nm+orange 610 nm from specific specific photodiode ADC 24-bit from specific specific 100-3,200 Hz over-sampled from specific specific motion artifact rejection from specific specific accelerometer subtraction from specific specific ICA independent component analysis from specific specific WPPG wrist PPG from specific specific 3.5-15% motion noise reduction from specific specific ±3 bpm HR accuracy vs. specific specific Holter at specific specific 95% CI from specific specific blood pressure cuff-less at specific specific PTT pulse transit time dual-site wrist+finger from specific specific Omron HEM from specific specific SBP ±8 mmHg at specific specific AAMI ES60601; specific specific PAT peripheral arterial tonometry: specific specific pneumatic finger probe+PPG from specific specific arterial pulse wave from specific specific sympathetic nervous system SNS tone from specific specific AHI apnea-hypopnea index prediction at specific specific 92% sensitivity 83% specificity vs. specific specific PSG gold standard from specific specific Itamar WatchPAT patent for specific specific home sleep apnea test HSAT); ECG SINGLE-LEAD PATENTS: APPLE; ALIVECOR (KARDIA); WITHINGS; BIOTRICITY; FITBIT/GOOGLE: specific ECG innovations (specific specific KardiaMobile 6L: specific specific 6-lead from specific specific 4-electrode + specific specific single limb electrode at specific specific 1,000 Hz sampling from specific specific FDA cleared Class II De Novo from specific specific AF+flutter+normal+unclassified from specific specific AliveCor KAI algorithm from specific specific 99% sensitivity 97% specificity AF from specific specific ECG-on-demand smartphone from specific specific 30-second recording from specific specific Apple Watch ECG compliance at specific specific lead-I only vs. specific specific 6L from specific specific NightOwl sleep patch 14-day continuous Holter from specific specific 1-lead stick-on from specific specific 125 Hz from specific specific ambulatory QRS detection R-peak); SpO2 WEARABLE PATENTS: MASIMO; APPLE; SAMSUNG; NELLCOR/MEDTRONIC; NONIN: specific SpO2 (specific specific Masimo Total Haemoglobin SpHb LNOP: specific specific 8-wavelength from specific specific 620-1,000 nm from specific specific continuous non-invasive hemoglobin SpHb±1 g/dL at specific specific wrist from specific specific R-curve correction motion + specific specific ambient light rejection from specific specific APOD adaptive probe-off detection from specific specific Masimo SET rainbow from specific specific wrist ±2% SpO2 vs. specific specific finger oximeter Nellcor for specific specific hospital wearable; specific specific reflectance pulse ox: specific specific backscattered light at specific specific wrist site from specific specific red+IR reflectance vs. specific specific transmission fingertip at specific specific 500 Hz for specific specific adaptive filtering motion artifact from specific specific SaO₂ 70-100% ±2% at specific specific high-motion athlete).

CGM electrochemical sensor innovations for continuous glucose and multi-analyte biosensing; sweat and skin biomarker wearable sensor innovations; and inertial measurement unit IMU and gait analysis innovations represent three additional wearable biosensor patent domains: CGM ELECTROCHEMICAL PATENTS: DEXCOM; ABBOTT; MEDTRONIC GUARDIAN; SENSEONICS EVERSENSE; BIOLINQ: specific CGM innovations (specific specific long-wear subcutaneous CGM: specific specific GOx glucose oxidase from specific specific immobilized in polyurethane from specific specific outer biocompatibility membrane from specific specific glucose diffusion limiting membrane from specific specific Pt anode at specific specific +0.55 V vs. specific specific Ag/AgCl from specific specific H₂O₂ oxidation amperometric at specific specific pH 7.4 from specific specific 0.1 μA per mg/dL at specific specific 0.01 μA/cm² sensitivity from specific specific interference rejection uric acid+acetaminophen from specific specific interferant-rejecting inner membrane from specific specific 1,5-AG isoglycaemia +GOx on-board for specific specific time-in-range TIR >70% FDA qualification from specific specific 180-day implantable Senseonics Eversense 3); SWEAT BIOMARKER PATENTS: CALTECH GAO LAB; ECCRINE SYSTEMS; GRAPHWEAR; PROFUSA; EPICORE BIOSYSTEMS: specific sweat biosensors (specific specific microfluidic sweat patch: specific specific serpentine microfluidic channel 200 μm width from specific specific PDMS+polyethylene layer from specific specific NFC electronics from specific specific ion-selective electrodes ISE for specific specific Na⁺/K⁺/Cl⁻ at specific specific 0.1 mM-200 mM range from specific specific enzyme electrode for specific specific glucose+lactate at specific specific 0-20 mM sweat glucose from specific specific iontophoresis carbachol 2% for specific specific sweat stimulation from specific specific wireless CMOS NFC reader from specific specific cortisol immunosensor for specific specific stress biomarker from specific specific immunoelectrochemical ELISA at specific specific 1-100 ng/mL); IMU MOTION ANALYSIS PATENTS: APPLE; GARMIN; ZEPP/HUAMI; DORSAVI; STRYD: specific IMU innovations (specific specific gait analysis wearable: specific specific 3-axis accelerometer+gyroscope+magnetometer from specific specific 6-DOF IMU at specific specific 100-800 Hz sampling from specific specific FIR bandpass 1-20 Hz from specific specific ML gait cycle segmentation at specific specific HS heel strike+TO toe-off from specific specific step length+cadence+GRF ground reaction force estimation at specific specific ±5% RMSE vs. specific specific force plate from specific specific Stryd FootPod patented algorithm from specific specific 100 Hz piezo foot pod from specific specific wearable power meter watts output for specific specific running VO₂max estimation ±5% vs. specific specific laboratory CPET from specific specific Apple Watch crash detection 256g accel IMU).

Wearable sensor startup IP strategy must navigate the dominance of Apple (3,000+), Samsung, and Garmin in consumer wearable IP; respect Dexcom (1,000+) and Abbott (1,000+) in CGM; work around Masimo's extremely aggressive optical sensing IP enforcement posture; and identify genuine whitespace in multi-analyte sweat sensing, novel dermal optical sensing, and AI-driven predictive health algorithms: WEARABLE BIOSENSOR STARTUP IP STRATEGY: UNDERSTAND THE WEARABLE IP LANDSCAPE: APPLE HOLDS 3,000+ WEARABLE HEALTH PATENTS — EXTRAORDINARILY BROAD: Apple has the broadest wearable biosensor IP portfolio spanning ECG lead-I, PPG multi-wavelength, SpO2 reflectance, skin temperature, crash detection, and health AI algorithms — Apple has successfully enforced this IP (ITC exclusion order against Apple Watch for Masimo SpO2 import ban was reversed on presidential review); any consumer health wearable must carefully review Apple's portfolio; MASIMO HOLDS AGGRESSIVE PULSE OXIMETRY IP: Masimo (500+) holds very aggressive optical pulse oximetry IP including rainbow SET (multi-wavelength), motion-tolerant SpO2, and continuous non-invasive hemoglobin — Masimo vs. Apple Watch was one of the highest-profile wearable IP disputes with an initial ITC exclusion order reversed on national interest grounds; DEXCOM AND ABBOTT HOLD CORE CGM IP: Dexcom (1,000+) and Abbott (1,000+) hold the most commercially important CGM IP covering GOx enzyme electrochemistry, biocompatibility membranes, glucose diffusion limiting membranes, and wireless transmission — any subcutaneous or non-invasive glucose sensing startup needs extensive FTO against both; ALIVECOR HOLDS KEY SINGLE-LEAD ECG IP: AliveCor/Kardia holds important single-lead ECG mobile platform IP — relevant for consumer ECG monitoring startups; WHEN TO PATENT IN WEARABLE BIOSENSORS: NOVEL OPTICAL SENSING MODALITY WITH MEASURED CLINICAL ACCURACY: specific novel optical wearable sensor (specific specific wavelength combination + specific specific detector design + specific specific signal processing algorithm) with specific measured clinical accuracy (specific specific MARD%, specific specific ±X mmHg blood pressure vs. specific specific AAMI ES60601 validation, specific specific %SpO2 agreement vs. specific specific co-oximetry at specific specific 70-100% SaO₂ range, specific specific sensitivity/specificity for specific specific arrhythmia vs. specific specific Holter gold standard) vs. specific specific Apple Watch or specific specific Masimo clinical-grade baseline at specific specific same physiological condition — clinical accuracy data vs. cleared device baseline is the key wearable biosensor IP differentiator; NOVEL CGM SENSOR WITH MEASURED MARD AND CALIBRATION-FREE OPERATION: specific novel glucose sensing system (specific specific enzyme/chemistry + specific specific membrane architecture + specific specific calibration approach) with specific measured performance (specific specific MARD % vs. specific specific YSI reference at specific specific 40-400 mg/dL range, specific specific wear duration days, specific specific factory calibration vs. specific specific fingerstick calibration requirement, specific specific ISPAD ATTD consensus ±15% in 80%+ readings) vs. specific specific Dexcom G7 MARD 8.2% or specific specific Libre 3 MARD 7.8% baseline — MARD vs. iCGM benchmark is the key CGM IP metric and aligns with FDA iCGM 510k pathway; NOVEL SWEAT OR SKIN BIOMARKER WITH MEASURED CORRELATION TO BLOOD REFERENCE: specific novel sweat or skin wearable sensor (specific specific biosensor modality + specific specific analyte + specific specific sweat stimulation if needed) with specific measured correlation (specific specific r² ≥0.7 correlation coefficient vs. specific specific blood reference at specific specific physiological range, specific specific Bland-Altman mean bias ±X% at specific specific limits of agreement) at specific specific validated analyte concentration range — correlation to blood reference biomarker creates the clinical validity data needed for wearable biosensor IP claims and FDA regulatory strategy; AI ALGORITHM IP: FDA-cleared SaMD software as a medical device algorithms (AF detection, apnea detection, ECG interpretation) represent patentable AI-driven health monitoring innovations when anchored to specific sensor input + specific ML architecture + specific validated clinical endpoint; KEY FTO CHECKLIST: Apple Watch ECG lead-I 5-electrode Ti 256-500 Hz 30s AF PPV 98.5% FDA 510k; Apple Watch PPG 3-LED red+green+IR ±2% SpO2; Dexcom G7 CGM GOx 10-day MARD 8.2% iCGM FDA De Novo 2020 40-400 mg/dL 5 min BLE direct-to-watch; Abbott Libre 3 FSL3 14-day 60s NFC MARD 7.8% factory-calibrated no fingerstick iCGM FDA 2022; Masimo rainbow SET multi-wavelength 8-channel 620-1,000 nm SpHb±1 g/dL APOD adaptive probe-off motion rejection; AliveCor KardiaMobile 6L 1,000 Hz FDA Class II De Novo AF 99% sensitivity 97% specificity; Caltech Gao microfluidic sweat patch 200 μm PDMS NFC ISE Na⁺/K⁺/Cl⁻ GOx glucose+lactate iontophoresis carbachol cortisol immunosensor; Stryd FootPod 100 Hz piezo gait HS TO step cadence GRF ±5% vs. force plate VO₂max ±5%; Senseonics Eversense 180-day implantable GOx subcutaneous TIR >70% FDA.